RESUMEN
The Zika virus (ZIKV) epidemic in Brazil occurred in regions where dengue viruses (DENV) are historically endemic. We investigated the differences in adverse pregnancy/infant outcomes in two cohorts comprising 114 pregnant women with PCR-confirmed ZIKV infection in Rio de Janeiro, Southeastern Brazil (n = 50) and Manaus, in the north region of the country (n = 64). Prior exposure to DENV was evaluated through plaque reduction neutralizing antibody assays (PRNT 80) and DENV IgG serologies. Potential associations between pregnancy outcomes and Zika attack rates in the two cities were explored. Overall, 31 women (27%) had adverse pregnancy/infant outcomes, 27 in Rio (54%) and 4 in Manaus (6%), p < 0.001. This included 4 pregnancy losses (13%) and 27 infants with abnormalities at birth (24%). A total of 93 women (82%) had evidence of prior DENV exposure, 45 in Rio (90%) and 48 in Manaus (75%). Zika attack rates differed; the rate in Rio was 10.28 cases/10,000 and in Manaus, 0.6 cases/10,000, p < 0.001. Only Zika attack rates (Odds Ratio: 17.6, 95% Confidence Interval 5.6-55.9, p < 0.001) and infection in the first trimester of pregnancy (OR: 4.26, 95% CI 1.4-12.9, p = 0.011) were associated with adverse pregnancy and infant outcomes. Pre-existing immunity to DENV was not associated with outcomes (normal or abnormal) in patients with ZIKV infection during pregnancy.
Asunto(s)
Complicaciones Infecciosas del Embarazo/epidemiología , Complicaciones Infecciosas del Embarazo/virología , Resultado del Embarazo , Infección por el Virus Zika/epidemiología , Infección por el Virus Zika/virología , Virus Zika , Adulto , Anticuerpos Antivirales , Brasil/epidemiología , Estudios de Cohortes , Coinfección , Dengue/diagnóstico , Dengue/epidemiología , Dengue/virología , Femenino , Evaluación del Impacto en la Salud , Humanos , Recién Nacido , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Prevalencia , Vigilancia en Salud Pública , Factores de Riesgo , Adulto Joven , Virus Zika/inmunología , Infección por el Virus Zika/diagnósticoRESUMEN
BACKGROUND: Zika virus (ZIKV) has been linked to central nervous system malformations in fetuses. To characterize the spectrum of ZIKV disease in pregnant women and infants, we followed patients in Rio de Janeiro to describe clinical manifestations in mothers and repercussions of acute ZIKV infection in infants. METHODS: We enrolled pregnant women in whom a rash had developed within the previous 5 days and tested blood and urine specimens for ZIKV by reverse-transcriptase-polymerase-chain-reaction assays. We followed women prospectively to obtain data on pregnancy and infant outcomes. RESULTS: A total of 345 women were enrolled from September 2015 through May 2016; of these, 182 women (53%) tested positive for ZIKV in blood, urine, or both. The timing of acute ZIKV infection ranged from 6 to 39 weeks of gestation. Predominant maternal clinical features included a pruritic descending macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (short-term and low-grade). By July 2016, a total of 134 ZIKV-affected pregnancies and 73 ZIKV-unaffected pregnancies had reached completion, with outcomes known for 125 ZIKV-affected and 61 ZIKV-unaffected pregnancies. Infection with chikungunya virus was identified in 42% of women without ZIKV infection versus 3% of women with ZIKV infection (P<0.001). Rates of fetal death were 7% in both groups; overall adverse outcomes were 46% among offspring of ZIKV-positive women versus 11.5% among offspring of ZIKV-negative women (P<0.001). Among 117 live infants born to 116 ZIKV-positive women, 42% were found to have grossly abnormal clinical or brain imaging findings or both, including 4 infants with microcephaly. Adverse outcomes were noted regardless of the trimester during which the women were infected with ZIKV (55% of pregnancies had adverse outcomes after maternal infection in the first trimester, 52% after infection in the second trimester, and 29% after infection in the third trimester). CONCLUSIONS: Despite mild clinical symptoms in the mother, ZIKV infection during pregnancy is deleterious to the fetus and is associated with fetal death, fetal growth restriction, and a spectrum of central nervous system abnormalities. (Funded by Ministério da Saúde do Brasil and others.).
Asunto(s)
Sistema Nervioso Central/anomalías , Muerte Fetal , Retardo del Crecimiento Fetal/virología , Microcefalia/virología , Complicaciones Infecciosas del Embarazo , Infección por el Virus Zika/complicaciones , Virus Zika/aislamiento & purificación , Adolescente , Adulto , Encéfalo/anomalías , Brasil/epidemiología , Sistema Nervioso Central/embriología , Femenino , Muerte Fetal/etiología , Retardo del Crecimiento Fetal/epidemiología , Feto/anomalías , Edad Gestacional , Humanos , Persona de Mediana Edad , Embarazo , Nacimiento Prematuro/epidemiología , Ultrasonografía Prenatal , Adulto JovenRESUMEN
As propriedades larvicidas de 34 extratos, provenientes de 29 vegetais, foram testados em larvas de Aedes fluviatilis (Lutz) (Diptera: Culicidae) nas concentraçöes de 100, 10 e 1 ppm. 26,5% dos exames utilizados, reduziram significamente a sobrevida larvária (alfa = 0,05), quando empregados na concentraçäo de 100 ppm (Anacardium occidentale, Agave americana, Allium sativum, Coriandrum sativum, Nerium oleander, Spatodea campanulata, Tibouchina scrobiculata e Vernonia salzmanni). O ácido anacárdio (A. occidentale) mostrou-se larvicida na concentraçäo de 10 ppm e o extrato bruto de A. sativum foi eficaz contra as larvas na concentraçäo de 1 ppm